EE9700326A - Rakuliin analgeetiliste ühendite tootmiseks valu ravimiseks - Google Patents

Rakuliin analgeetiliste ühendite tootmiseks valu ravimiseks

Info

Publication number
EE9700326A
EE9700326A EE9700326A EE9700326A EE9700326A EE 9700326 A EE9700326 A EE 9700326A EE 9700326 A EE9700326 A EE 9700326A EE 9700326 A EE9700326 A EE 9700326A EE 9700326 A EE9700326 A EE 9700326A
Authority
EE
Estonia
Prior art keywords
pain
treatment
production
cell line
analgesic compounds
Prior art date
Application number
EE9700326A
Other languages
English (en)
Estonian (et)
Inventor
Saydoff Joel
Wong Shou
Original Assignee
Cytotherapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytotherapeutics, Inc. filed Critical Cytotherapeutics, Inc.
Publication of EE9700326A publication Critical patent/EE9700326A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0071Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70Enkephalins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Plant Pathology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Pain & Pain Management (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EE9700326A 1995-06-07 1996-06-07 Rakuliin analgeetiliste ühendite tootmiseks valu ravimiseks EE9700326A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48191795A 1995-06-07 1995-06-07
PCT/US1996/009629 WO1996040959A1 (en) 1995-06-07 1996-06-07 Cell line producing analgesic compounds for treating pain

Publications (1)

Publication Number Publication Date
EE9700326A true EE9700326A (et) 1998-06-15

Family

ID=23913905

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700326A EE9700326A (et) 1995-06-07 1996-06-07 Rakuliin analgeetiliste ühendite tootmiseks valu ravimiseks

Country Status (20)

Country Link
EP (1) EP0833935A1 (enEXAMPLES)
JP (1) JPH11507530A (enEXAMPLES)
KR (1) KR19990022414A (enEXAMPLES)
CN (1) CN1192246A (enEXAMPLES)
AR (1) AR004494A1 (enEXAMPLES)
AU (1) AU6263696A (enEXAMPLES)
BR (1) BR9608746A (enEXAMPLES)
CA (1) CA2223246A1 (enEXAMPLES)
CZ (1) CZ392497A3 (enEXAMPLES)
EE (1) EE9700326A (enEXAMPLES)
HU (1) HUP9901191A2 (enEXAMPLES)
IL (1) IL122415A0 (enEXAMPLES)
IN (1) IN181898B (enEXAMPLES)
IS (1) IS4628A (enEXAMPLES)
NO (1) NO975545L (enEXAMPLES)
PL (1) PL323867A1 (enEXAMPLES)
SK (1) SK167997A3 (enEXAMPLES)
TR (1) TR199701520T1 (enEXAMPLES)
WO (1) WO1996040959A1 (enEXAMPLES)
ZA (1) ZA964880B (enEXAMPLES)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999028449A2 (en) * 1997-11-28 1999-06-10 Medical Research Council Yac vectors
WO2000016799A1 (en) * 1998-09-23 2000-03-30 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Methods of treating chronic pain
ATE312916T1 (de) * 1998-10-27 2005-12-15 Anticancer Inc Herstellung eines retrovirus, welches den mel- lokus von streptomyces enthält, sowie dessen expression in säugetierzellen
US6372489B1 (en) 1998-10-27 2002-04-16 Anticancer, Inc. Method and model for hair pigmentation
US6903244B1 (en) 1999-02-26 2005-06-07 University Of Utah Research Foundation Mice which are +/− or −/− for the elastin gene as models for vascular disease
AU2002952993A0 (en) 2002-11-29 2002-12-12 The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland Therapeutic and diagnostic agents
WO2005060992A1 (en) 2003-12-24 2005-07-07 The Walter And Eliza Hall Institute Of Medical Research Therapeutic agents and uses therefor
NZ551828A (en) 2004-05-12 2009-03-31 Inst Medical W & E Hall A method of cell isolating a homogenous population of mammary stem cells using specific cell surface marker proteins
WO2006135985A1 (en) 2005-06-24 2006-12-28 The Walter And Eliza Hall Institute Of Medical Research Therapeutic pro-apoptotic bh3-like molecules and methods for generating and/or selecting the same
AU2007275764B2 (en) 2006-07-18 2013-11-14 University Of Utah Research Foundation Methods for treating pain and screening analgesic compounds
US8889173B2 (en) * 2008-04-18 2014-11-18 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
HK1221425A1 (zh) 2013-05-31 2017-06-02 University Of Utah Research Foundation 芋螺毒素(conotoxin)肽,其醫藥組合物和用途
CA3003294A1 (en) 2015-10-27 2017-05-04 The University Of Queensland Modified epha4 and uses thereof
CN107964047B (zh) * 2017-12-18 2018-11-02 哈尔滨工业大学 基于内吗啡肽-1和神经降压素(8-13)的嵌合肽及其合成方法和应用
CN112891337A (zh) * 2021-03-26 2021-06-04 河北医科大学 高良姜素及其衍生物在制备预防和治疗神经系统疾病药物中的用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4098355B2 (ja) * 1993-08-12 2008-06-11 ニューロテック ユーエスエー, インコーポレイテッド 遺伝的に改変された細胞を含む生体適合性免疫隔離カプセル

Also Published As

Publication number Publication date
IS4628A (is) 1997-12-04
WO1996040959A1 (en) 1996-12-19
SK167997A3 (en) 1998-05-06
KR19990022414A (ko) 1999-03-25
EP0833935A1 (en) 1998-04-08
CZ392497A3 (cs) 1998-12-16
BR9608746A (pt) 1999-05-11
CA2223246A1 (en) 1996-12-19
AU6263696A (en) 1996-12-30
HUP9901191A2 (hu) 1999-08-30
PL323867A1 (en) 1998-04-27
IL122415A0 (en) 1998-06-15
IN181898B (enEXAMPLES) 1998-10-24
ZA964880B (en) 1997-01-07
TR199701520T1 (xx) 1998-04-21
NO975545L (no) 1998-02-04
NO975545D0 (no) 1997-12-02
CN1192246A (zh) 1998-09-02
AR004494A1 (es) 1998-12-16
JPH11507530A (ja) 1999-07-06

Similar Documents

Publication Publication Date Title
EE9800194A (et) Uued valuvaigistava toimega ühendid
DE69630305D1 (de) Elektrodenkatheter
EE9700326A (et) Rakuliin analgeetiliste ühendite tootmiseks valu ravimiseks
IS4434A (is) Efnasamband til lækninga á krabbameini
GB9506087D0 (en) Improvements relating to medical injection devices
DK0769017T3 (da) Terapeutiske forbindelser
PL324078A1 (en) Application of bis-1,2,4-triazoles in production of a drug designed to treat carcinomas
NO941822D0 (no) Brönnsikt for ökt produksjon
AU5884496A (en) Therapeutic sepsis treatment using antagonists to pthrp
NO975660D0 (no) Anvendelse av benzimidazoler for fremstilling av et medikament for behandling av levkemi
BR9600809A (pt) Medicamento
DE69420609D1 (de) Piroxicam enthaltendes analgetisch-entzündungshemmmendes Pflaster
EE9800195A (et) Uudsed analgeetilise toimega ühendid
NO982582D0 (no) FremgangsmÕte for behandling av smerte
DE69630073D1 (de) (-)Hydroxycitrat enthaltende Verbindungen mit neuen therapeutischen Wirkungen
DK0866699T3 (da) Anvendelse af cholinesteraseinhibitorer til fremstilling af et medikament til behandling af xerostomi
DE69606320D1 (de) Bohrlochbehandlungsflüssigkeit
LV11966A (lv) Pretiekaisumu lidzeklis arigai lietosanai
KR960037415U (ko) 전기분해에 의한 분뇨정화장치
EP0776666A3 (en) Analgesic and anti-inflammatory medication
KR960022560U (ko) 폐수처리용 농축기
FI960880A7 (fi) Menetelmä reagoimattoman propeenin puhdistamiseksi polypropeenin valmistuksessa
KR970038990U (ko) 후처리 정화조
SE9504669D0 (sv) Positionerbar behandlingskateter
EE00077U1 (et) BIO-tüüpi reoveepuhasti